Telesso Technologies Limited (ASX:TEO),
a global healthcare company, announced today the FDA-approved guide
wire-assisted peripheral IV catheter it is developing with Vascular
Pathways, Inc., has been honored with the Popular Science Invention
Award.
“Telesso is pleased to receive another exciting external validation of
this innovative device that may revolutionize peripheral IV placement,”
said Telesso’s CEO Nelson K. Stacks. “Attempts to start an IV frequently
fail, which is frustrating for clinicians, painful for patients and
costly to the health care system. The new guide-wire assisted peripheral
IV catheter uses a practical design to improve the ability for
clinicians to get it right the first time, creating efficiency,
enhancing safety, reducing costs, and avoiding the need for re-sticks.”
A post-market trial is currently comparing patients treated with
Telesso’s catheter to the industry’s gold standard device for peripheral
IV placement. Data review is expected in Q2-Q3 2009.
About the Guide Wire-Assisted Peripheral IV Catheter
A peripheral vein is the most common site for insertion of a catheter
for short-term diagnostic or therapeutic use. The catheter is placed
into the peripheral vein in the arm and is typically passed up inside
the vein to a length of 2-3 inches. Telesso’s uniquely-designed guide
wire-assisted peripheral IV catheter device uses a first-in-class
retractable nitinol guide wire system that is believed to enable easier
IV access, reduce common safety risks, significantly lessen patient pain
and discomfort, and provide cost savings to facilities by lowering
administrative costs associated with failed IV starts. Telesso believes
this catheter device is the first clinically meaningful advancement in
peripheral IV access since automatic needle retraction catheters and
addresses significant unmet needs in peripheral intravenous access.
About the Telesso-VPI Agreement
Telesso Technologies Limited announced in December 2008 that it entered
into a strategic agreement with Vascular Pathways, Inc. (VPI), a private
company based in California, to co-develop VPI’s guide wire-assisted
device with the funding of the clinical trial and to potentially acquire
VPI.
For more information, visit Telesso’s web site at http://www.telesso.com.
Telesso Technologies
Ian Atkin, +61 2 9805 0022
Chief
Financial Officer, Australia
atkin@telesso.com
Jeff
Riley, +1-619-309-7661
President, USA
riley@telesso.com
